Robert Mark Dolman, D.D.S.MSC
Oral and Maxillofacial Pathology Dentistry · New York, NY
Robert Mark Dolman, D.D.S.MSC is an oral and maxillofacial pathology dentistry with a practice address in New York, New York, and NPI 1023198793, issued on Oct 17, 2006. Check the license (New York 054277, as entered in NPPES) with the New York board that licenses this profession; the Medicare figures below come from public CMS files.
- Name
- Robert Mark Dolman
- Credential
- D.D.S.MSC
- Primary taxonomy
- Oral and Maxillofacial Pathology Dentistry 1223P0106X
- License number
- 054277 NY
Self-reported in NPPES; status is on the state search - Practice location
- 12 E 41St St, New York, NY 10017
- Phone
- (212) 696-0167
- Enumerated
- Oct 17, 2006
- Record last updated
- Mar 25, 2016 (not updated in 10 years: call before relying on the address or phone)
- Fax
- (917) 463-0296
- Entity
- Type 1 · individual
8 nearest oral and maxillofacial pathology dentistry records → All 66 in New York → Look up another NPI →
Also registered at 12 E 41St St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Gary Coelho, DDSProsthodontics1851628267
- Dominic Galasso, DDSProsthodontics1891022216
- Sanjay Jagani, D.D.S.General Practice Dentistry1073725131
- Michele Landolt, D.M.DProsthodontics1154594430
- Yelena Simkha, DDSGeneral Practice Dentistry1043471840
Verify Robert Mark Dolman in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersWhich New York board licenses this profession
Search for license 054277Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
43% fewer Medicare Part D claims than the average oral and maxillofacial pathology dentistry in 2024
162 Medicare Part D claims for 58 beneficiaries, against an average of 284 among the 269 providers of this specialty who prescribed in Part D. Brand-name drugs were 0% of claims. 13 claims were for opioids.
Most prescribed
- Amoxicillin47 claims
- Ibuprofen40 claims
- Chlorhexidine Gluconate29 claims
- Oxycodone-Acetaminophen13 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $65.84
1 payment: food and beverage; the largest payer was Southern Anesthesia & Surgical, Inc (dba Ace Southern). The 130 providers of this specialty with any payment received $1,322.50 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Robert Mark Dolman among 66 oral and maxillofacial pathology dentistry records in New York
Robert Mark Dolman, D.D.S.MSC is one of 66 oral and maxillofacial pathology dentistry records with a practice address in New York. 65% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2006, is newer than 15% of them.
- NPI issued2006 · 15% of these records are older, 47% newer
- In a Medicare fileYes · 65% of these records are
- In the CMS Doctors and Clinicians fileNo · 24% of these records are
- Record last updated2016 · 68% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 1223P0106X and a New York practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Oral and Maxillofacial Pathology Dentistry providers in New York
There are 66 oral and maxillofacial pathology dentistry records in New York.
All 66 in New York → Every provider in New York → Oral and Maxillofacial Pathology Dentistry nationwide →
The 8 oral and maxillofacial pathology dentistry records with the nearest ZIP codes
- Aaron Yancoskie, D.D.S.New York, NY 100191295094670
- Pasquale Malpeso, D.M.D.New York, NY 100211073647772
- Arthi Rajan, D.D.S.New York, NY 100101497199509
- Anthony Vernillo, D.D.S., PH.D., MBENew York, NY 100101649492406
- Soo-Yeon SohnNew York, NY 100291912599879
- Brandon Veremis, D.D.S.New York, NY 100291487067948
- Robert MaimoneNew York, NY 100031447399340
- Alan Schwimmer, DDSNew York, NY 100031841333804
Common questions
What is Robert Mark Dolman, D.D.S.MSC's NPI number?
Robert Mark Dolman, D.D.S.MSC's National Provider Identifier (NPI) is 1023198793, issued on Oct 17, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Robert Mark Dolman, D.D.S.MSC located?
The NPPES record lists a practice address at 12 E 41St St, New York, NY, 10017. Phone: (212) 696-0167. Providers update this record themselves, so call before visiting.
How can I verify Robert Mark Dolman, D.D.S.MSC's license?
NPPES lists New York license number 054277, as entered by the provider. Search the New York board that licenses this profession; the NPPES record confirms identity only.
How much does Robert Mark Dolman, D.D.S.MSC prescribe under Medicare Part D?
In 2024, Robert Mark Dolman, D.D.S.MSC had 162 Medicare Part D claims for 58 beneficiaries; the average among oral and maxillofacial pathology dentistry prescribers was 284. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.